Report Detail

Pharma & Healthcare COVID-19 Impact on Global Finasteride Market Insights, Forecast to 2026

  • RnM3985411
  • |
  • 03 June, 2020
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Finasteride is a prescription drug in tablet form.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Finasteride market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Finasteride industry.
Based on our recent survey, we have several different scenarios about the Finasteride YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Finasteride will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Finasteride market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Finasteride market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Finasteride market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Finasteride market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Finasteride market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Finasteride market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Finasteride market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Finasteride market.
The following manufacturers are covered in this report:
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Finasteride Breakdown Data by Type
1mg Tablet
5mg Tablet
Finasteride Breakdown Data by Application
Medical Uses
Application 2


1 Study Coverage

  • 1.1 Finasteride Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Finasteride Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Finasteride Market Size Growth Rate by Type
    • 1.4.2 1mg Tablet
    • 1.4.3 5mg Tablet
  • 1.5 Market by Application
    • 1.5.1 Global Finasteride Market Size Growth Rate by Application
    • 1.5.2 Medical Uses
    • 1.5.3 Application 2
  • 1.6 Coronavirus Disease 2019 (Covid-19): Finasteride Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Finasteride Industry
      • 1.6.1.1 Finasteride Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Finasteride Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Finasteride Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Finasteride Market Size Estimates and Forecasts
    • 2.1.1 Global Finasteride Revenue 2015-2026
    • 2.1.2 Global Finasteride Sales 2015-2026
  • 2.2 Finasteride Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Finasteride Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Finasteride Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Finasteride Competitor Landscape by Players

  • 3.1 Finasteride Sales by Manufacturers
    • 3.1.1 Finasteride Sales by Manufacturers (2015-2020)
    • 3.1.2 Finasteride Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Finasteride Revenue by Manufacturers
    • 3.2.1 Finasteride Revenue by Manufacturers (2015-2020)
    • 3.2.2 Finasteride Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Finasteride Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Finasteride Revenue in 2019
    • 3.2.5 Global Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Finasteride Price by Manufacturers
  • 3.4 Finasteride Manufacturing Base Distribution, Product Types
    • 3.4.1 Finasteride Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Finasteride Product Type
    • 3.4.3 Date of International Manufacturers Enter into Finasteride Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Finasteride Market Size by Type (2015-2020)
    • 4.1.1 Global Finasteride Sales by Type (2015-2020)
    • 4.1.2 Global Finasteride Revenue by Type (2015-2020)
    • 4.1.3 Finasteride Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Finasteride Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Finasteride Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Finasteride Revenue Forecast by Type (2021-2026)
    • 4.2.3 Finasteride Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Finasteride Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Finasteride Market Size by Application (2015-2020)
    • 5.1.1 Global Finasteride Sales by Application (2015-2020)
    • 5.1.2 Global Finasteride Revenue by Application (2015-2020)
    • 5.1.3 Finasteride Price by Application (2015-2020)
  • 5.2 Finasteride Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Finasteride Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Finasteride Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Finasteride Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Finasteride by Country
    • 6.1.1 North America Finasteride Sales by Country
    • 6.1.2 North America Finasteride Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Finasteride Market Facts & Figures by Type
  • 6.3 North America Finasteride Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Finasteride by Country
    • 7.1.1 Europe Finasteride Sales by Country
    • 7.1.2 Europe Finasteride Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Finasteride Market Facts & Figures by Type
  • 7.3 Europe Finasteride Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Finasteride by Region
    • 8.1.1 Asia Pacific Finasteride Sales by Region
    • 8.1.2 Asia Pacific Finasteride Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Finasteride Market Facts & Figures by Type
  • 8.3 Asia Pacific Finasteride Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Finasteride by Country
    • 9.1.1 Latin America Finasteride Sales by Country
    • 9.1.2 Latin America Finasteride Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Finasteride Market Facts & Figures by Type
  • 9.3 Central & South America Finasteride Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Finasteride by Country
    • 10.1.1 Middle East and Africa Finasteride Sales by Country
    • 10.1.2 Middle East and Africa Finasteride Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Finasteride Market Facts & Figures by Type
  • 10.3 Middle East and Africa Finasteride Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Description, Business Overview and Total Revenue
    • 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck Finasteride Products Offered
    • 11.1.5 Merck Recent Development
  • 11.2 Actavis
    • 11.2.1 Actavis Corporation Information
    • 11.2.2 Actavis Description, Business Overview and Total Revenue
    • 11.2.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Actavis Finasteride Products Offered
    • 11.2.5 Actavis Recent Development
  • 11.3 Sandoz
    • 11.3.1 Sandoz Corporation Information
    • 11.3.2 Sandoz Description, Business Overview and Total Revenue
    • 11.3.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sandoz Finasteride Products Offered
    • 11.3.5 Sandoz Recent Development
  • 11.4 Teva Pharmaceuticals
    • 11.4.1 Teva Pharmaceuticals Corporation Information
    • 11.4.2 Teva Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.4.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Teva Pharmaceuticals Finasteride Products Offered
    • 11.4.5 Teva Pharmaceuticals Recent Development
  • 11.5 Cipla
    • 11.5.1 Cipla Corporation Information
    • 11.5.2 Cipla Description, Business Overview and Total Revenue
    • 11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Cipla Finasteride Products Offered
    • 11.5.5 Cipla Recent Development
  • 11.6 RelonChem
    • 11.6.1 RelonChem Corporation Information
    • 11.6.2 RelonChem Description, Business Overview and Total Revenue
    • 11.6.3 RelonChem Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 RelonChem Finasteride Products Offered
    • 11.6.5 RelonChem Recent Development
  • 11.7 Dr. Reddy
    • 11.7.1 Dr. Reddy Corporation Information
    • 11.7.2 Dr. Reddy Description, Business Overview and Total Revenue
    • 11.7.3 Dr. Reddy Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Dr. Reddy Finasteride Products Offered
    • 11.7.5 Dr. Reddy Recent Development
  • 11.8 Accord Pharmaceuticals
    • 11.8.1 Accord Pharmaceuticals Corporation Information
    • 11.8.2 Accord Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.8.3 Accord Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Accord Pharmaceuticals Finasteride Products Offered
    • 11.8.5 Accord Pharmaceuticals Recent Development
  • 11.9 Henan Topfond
    • 11.9.1 Henan Topfond Corporation Information
    • 11.9.2 Henan Topfond Description, Business Overview and Total Revenue
    • 11.9.3 Henan Topfond Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Henan Topfond Finasteride Products Offered
    • 11.9.5 Henan Topfond Recent Development
  • 11.10 Zhejiang CONBA Pharmaceutical
    • 11.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
    • 11.10.2 Zhejiang CONBA Pharmaceutical Description, Business Overview and Total Revenue
    • 11.10.3 Zhejiang CONBA Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Products Offered
    • 11.10.5 Zhejiang CONBA Pharmaceutical Recent Development
  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Description, Business Overview and Total Revenue
    • 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck Finasteride Products Offered
    • 11.1.5 Merck Recent Development
  • 11.12 Guangdong Eashu Pharmacetical
    • 11.12.1 Guangdong Eashu Pharmacetical Corporation Information
    • 11.12.2 Guangdong Eashu Pharmacetical Description, Business Overview and Total Revenue
    • 11.12.3 Guangdong Eashu Pharmacetical Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Guangdong Eashu Pharmacetical Products Offered
    • 11.12.5 Guangdong Eashu Pharmacetical Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Finasteride Market Estimates and Projections by Region
    • 12.1.1 Global Finasteride Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Finasteride Revenue Forecast by Regions 2021-2026
  • 12.2 North America Finasteride Market Size Forecast (2021-2026)
    • 12.2.1 North America: Finasteride Sales Forecast (2021-2026)
    • 12.2.2 North America: Finasteride Revenue Forecast (2021-2026)
    • 12.2.3 North America: Finasteride Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Finasteride Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Finasteride Sales Forecast (2021-2026)
    • 12.3.2 Europe: Finasteride Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Finasteride Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Finasteride Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Finasteride Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Finasteride Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Finasteride Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Finasteride Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Finasteride Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Finasteride Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Finasteride Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Finasteride Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Finasteride Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Finasteride Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Finasteride Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Finasteride Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Finasteride Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Finasteride. Industry analysis & Market Report on COVID-19 Impact on Global Finasteride is a syndicated market report, published as COVID-19 Impact on Global Finasteride Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Finasteride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,112.20
    4,668.30
    6,224.40
    3,638.70
    5,458.05
    7,277.40
    599,664.00
    899,496.00
    1,199,328.00
    325,494.00
    488,241.00
    650,988.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report